Pregnancy and fertility rapid tests are point of care tests used to qualitatively detect the presence of reproductive hormones, such as Follicle Stimulating Hormone (FSH), Luteinising Hormone (LH) and Human Chorionic Gonadotropin (hCG) hormone. Fertility rapid test kits can help find the exact day of ovulation or confirm the presence of menopause in women, while in males, they are used to detect the sperm count. These tests require small amount of blood or urine sample, depending upon the type of device being used; these devices work on colour changing immunoassay techniques. The global fertility and pregnancy rapid test kits market has been segmented on the basis of product type, test type, distribution channels, and region.
Growth of the global fertility and pregnancy market is mainly driven by rising demand for fast and self-contained tests, growing incidence of infertility and gynaecological disorders, availability of decentralised diagnostic tests over time-consuming laboratory tests, and increasing first-time pregnancy age.Technological advancements and attractive product features such as smartphone app connectivity are also driving adoption of fertility and pregnancy rapid test kits.
However, paradox of choice due to availability of too many options in the market, low adoption of these products in countries having inherent potential, and device related issues and controversies can impede growth of the market.
Premier players in this market are employing strategies of creating alliances with e-commerce partners and maintaining distribution agreements with strong local players in regions such as Western Europe and APEJ to consolidate their position.